NAFLD (Nonalcoholic Fatty Liver Disease) Clinical Trials
2 recruiting trials for NAFLD (Nonalcoholic Fatty Liver Disease). Eligibility criteria explained in plain English.
TrialFinderData lists 2 NAFLD (Nonalcoholic Fatty Liver Disease) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Beijing Tsinghua Chang Gung Hospital (1), University of California, San Diego (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is None-placebo (other, 1 trial), followed by LiverScope® exam, MR exam.
Track NAFLD (Nonalcoholic Fatty Liver Disease) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Digital Early Warning System for Acute Lung Injury in Liver Surgery
This study focuses on developing an explainable machine learning model based on cardiopulmonary interaction characteristics to achieve early prediction of acute lung injury (ALI)...
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. This is the second phase of a project in which we are testing a...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for NAFLD (Nonalcoholic Fatty Liver Disease), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for NAFLD (Nonalcoholic Fatty Liver Disease), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for NAFLD (Nonalcoholic Fatty Liver Disease), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.